BR112022006863A2 - Sistemas e métodos de isolamento de gálio-68 - Google Patents
Sistemas e métodos de isolamento de gálio-68Info
- Publication number
- BR112022006863A2 BR112022006863A2 BR112022006863A BR112022006863A BR112022006863A2 BR 112022006863 A2 BR112022006863 A2 BR 112022006863A2 BR 112022006863 A BR112022006863 A BR 112022006863A BR 112022006863 A BR112022006863 A BR 112022006863A BR 112022006863 A2 BR112022006863 A2 BR 112022006863A2
- Authority
- BR
- Brazil
- Prior art keywords
- gallium
- methods
- insulation systems
- systems
- intended
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- GYHNNYVSQQEPJS-YPZZEJLDSA-N Gallium-68 Chemical compound [68Ga] GYHNNYVSQQEPJS-YPZZEJLDSA-N 0.000 title abstract 2
- 238000009413 insulation Methods 0.000 title 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
- B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/265—Adsorption chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/02—Column or bed processes
- B01J47/026—Column or bed processes using columns or beds of different ion exchange materials in series
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
- G21G2001/0021—Gallium
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Manufacture And Refinement Of Metals (AREA)
- Catalysts (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Recrystallisation Techniques (AREA)
Abstract
SISTEMAS E MÉTODOS DE ISOLAMENTO DE GÁLIO-68. Em um aspecto, a divulgação se refere a processos para preparação de uma solução de Ga-68 livre de carreador a partir de um conjunto de alvo sólido, sistemas que compreendem componentes usados nos processos divulgados e composições que compreendem Ga-68 preparadas pelos processos divulgados. Este resumo pretende ser uma ferramenta de digitalização para fins de pesquisa na técnica em particular e não tem a intenção de ser limitante da presente divulgação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962914476P | 2019-10-12 | 2019-10-12 | |
PCT/IB2020/059581 WO2021070164A1 (en) | 2019-10-12 | 2020-10-12 | Systems and methods of isolation of gallium-68 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112022006863A2 true BR112022006863A2 (pt) | 2022-07-05 |
BR112022006863A8 BR112022006863A8 (pt) | 2022-08-02 |
Family
ID=75438061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022006863A BR112022006863A8 (pt) | 2019-10-12 | 2020-10-12 | Sistemas e métodos de isolamento de gálio-68 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220351873A1 (pt) |
EP (1) | EP4041426A4 (pt) |
JP (1) | JP2022551697A (pt) |
KR (1) | KR20220093127A (pt) |
CN (1) | CN114761100A (pt) |
AU (1) | AU2020364423A1 (pt) |
BR (1) | BR112022006863A8 (pt) |
CA (1) | CA3156951A1 (pt) |
CR (1) | CR20220208A (pt) |
WO (1) | WO2021070164A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116594053B (zh) * | 2023-07-18 | 2024-01-19 | 清华大学 | 放射性溶液中超铀α核素、90Sr和137Cs的组分离系统及装置 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2461681A1 (fr) * | 1979-07-20 | 1981-02-06 | Rhone Poulenc Ind | Perfectionnement au procede de recuperation de l'uranium d'un acide phosphorique impur |
US5326441A (en) * | 1990-01-19 | 1994-07-05 | European Economic Community | Process for separating and concentrating gallium from an aqueous solution containing gallium, together with aluminum, zinc and copper |
GB0308407D0 (en) * | 2003-04-11 | 2003-05-21 | Amersham Plc | Method of obtaining 68 GA |
TW200740709A (en) * | 2005-07-26 | 2007-11-01 | Dro Biosystems S L | Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
KR20110106895A (ko) * | 2008-12-22 | 2011-09-29 | 바이엘 파마 악티엔게젤샤프트 | 교환 수지를 사용하여 방사성핵종-표지된 화합물을 합성하는 방법 |
FR3019547B1 (fr) * | 2014-04-03 | 2017-12-22 | Univ Paris Sud 11 | Nouveaux complexes pour la separation de cations |
US10522261B2 (en) * | 2014-05-15 | 2019-12-31 | Mayo Foundation For Medical Education And Research | Solution target for cyclotron production of radiometals |
PT3101660T (pt) * | 2015-06-05 | 2017-09-18 | Ion Beam Appl Sa | Processo de produção de gálio-68 através de irradiação de um alvo em solução |
US10835895B2 (en) * | 2016-04-01 | 2020-11-17 | The University Of Tokyo | Compound and synthesis method therefor |
EP3443001A4 (en) * | 2016-04-11 | 2020-04-29 | Obsidian Therapeutics, Inc. | REGULATED BIOCIRCUIT SYSTEMS |
EP3503929B1 (en) * | 2016-08-26 | 2022-02-23 | Mayo Foundation for Medical Education and Research | Rapid isolation of cyclotron-produced gallium-68 |
BR112020002016A2 (pt) * | 2017-07-31 | 2020-07-28 | Stefan Zeisler | sistema, aparelho e método para produzir radioisótopos de gálio em aceleradores de partículas usando alvos sólidos e composição de ga-68 produzida pelos mesmos |
US11986815B2 (en) * | 2018-12-11 | 2024-05-21 | Societe De Commercialisation Des Produits De La Recherche Appliquée Socpra Sciences Sante Et Humaines S.E.C. | Processes and systems for producing and/or purifying gallium-68 |
-
2020
- 2020-10-12 WO PCT/IB2020/059581 patent/WO2021070164A1/en active Application Filing
- 2020-10-12 CA CA3156951A patent/CA3156951A1/en active Pending
- 2020-10-12 BR BR112022006863A patent/BR112022006863A8/pt not_active Application Discontinuation
- 2020-10-12 JP JP2022521634A patent/JP2022551697A/ja active Pending
- 2020-10-12 EP EP20874202.3A patent/EP4041426A4/en not_active Withdrawn
- 2020-10-12 AU AU2020364423A patent/AU2020364423A1/en active Pending
- 2020-10-12 KR KR1020227015702A patent/KR20220093127A/ko unknown
- 2020-10-12 CR CR20220208A patent/CR20220208A/es unknown
- 2020-10-12 US US17/767,039 patent/US20220351873A1/en active Pending
- 2020-10-12 CN CN202080072686.9A patent/CN114761100A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3156951A1 (en) | 2021-04-15 |
CN114761100A (zh) | 2022-07-15 |
WO2021070164A1 (en) | 2021-04-15 |
JP2022551697A (ja) | 2022-12-13 |
EP4041426A1 (en) | 2022-08-17 |
EP4041426A4 (en) | 2022-11-23 |
AU2020364423A1 (en) | 2022-04-21 |
BR112022006863A8 (pt) | 2022-08-02 |
US20220351873A1 (en) | 2022-11-03 |
CR20220208A (es) | 2022-09-14 |
KR20220093127A (ko) | 2022-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016028219A2 (pt) | composto, método de tratamento ou prevenção do câncer, de uma doença infecciosa, ou de uma doença designada por aberração de metabolismo de energia celular em um indivíduo, método de tratamento ou prevenção de leucemia, câncer de pulmão de não pequenas células, carcinoma hepatocelular, ou glioblastomas em um indivíduo, método de tratamento de uma doença ou distúrbio em um indivíduo, composição farmacêutica e processo para obtenção de um composto de fórmula (i) | |
BR112014009146A2 (pt) | formulações de etanercepte estabilizadas com aminoácidos | |
CO7170149A2 (es) | Producción mejorada de derivados de ácidos grasos | |
MX2020003841A (es) | Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos. | |
BR112015005891A2 (pt) | método de sintetizar análogos do hormônio da tireoide e polimorfos destes | |
BR112015017869A2 (pt) | hidroalquilação aromtática de alquilo para a produção de plastificantes | |
CR20180503A (es) | Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos | |
BR112018011801A2 (pt) | ?método de produção de composições, composição e produto ingerível? | |
BR112014013098A2 (pt) | composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos | |
BR112017028509A2 (pt) | composições incluindo um politiol, um composto insaturado e um corante, e métodos relacionados a tais composições | |
BR112017008595A2 (pt) | composições e métodos referentes à beta-glucosidase | |
BR112014010920A2 (pt) | composição, e, método para preparar um (co)telômero | |
BR112016012627A2 (pt) | composições compreendendo um polipeptídeo de beta-glicosidase e métodos de uso | |
BR112018010499A8 (pt) | método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, população de células in vitro, método para produzir uma população de células, e população de células | |
BR112018013341A2 (pt) | composição adesiva, método de preparação de uma composição adesiva e produto adesivo | |
BR112018006519A2 (pt) | compostos de fórmula, processo para a síntese de compostos, compostos intermediários x, composição, utilização de um composto de fórmula, método para o combate de fungos e semente | |
BR112014007474A2 (pt) | aumento de rendimento de partícula tipo vírus em plantas | |
CO6590210A1 (es) | Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina | |
BR112018005871A2 (pt) | produção de composições de fosfato de cálcio | |
BR112015022520A2 (pt) | composições de ligante e métodos para produzir e usar as mesmas | |
CL2018000182A1 (es) | Compuesto que se dirige a il-23a y al factor de activación de linfocitos b (baff) y usos de estos | |
BR112023021160A2 (pt) | Lipídeos ionizáveis e composições para liberação em ácido nucleico | |
BR112017012473A2 (pt) | processo para a produção de sacarídeos sólidos a partir de uma solução aquosa de sacarídeos. | |
BR112022006863A2 (pt) | Sistemas e métodos de isolamento de gálio-68 | |
BR112017022395A2 (pt) | método para preparação de um agente de direcionamento de estrutura, e, composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |